<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">424</article-id><article-id pub-id-type="doi">10.15690/vramn.v69i5-6.1039</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>РATHOPHYSIOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ПАТОФИЗИОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CHEMILUMINESCENT AND ENZYME ACTIVITY OF NEUTROPHILS IN PATIENTS WITH WIDESPREAD PURULENT PERITONITIS DEPENDING ON THE OUTCOME OF DISEASE</article-title><trans-title-group xml:lang="ru"><trans-title>ХЕМИЛЮМИНЕСЦЕНТНАЯ И ЭНЗИМАТИЧЕСКАЯ АКТИВНОСТЬ НЕЙТРОФИЛЬНЫХ ГРАНУЛОЦИТОВ У БОЛЬНЫХ РАСПРОСТРАНЕННЫМ ГНОЙНЫМ ПЕРИТОНИТОМ В ЗАВИСИМОСТИ ОТ ИСХОДА ЗАБОЛЕВАНИЯ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Savchenko</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Савченко</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, professor, Head of the Laboratory of Molecular cell physiology and pathology of FSBI “Scientific research institute of medical problems of the North”, Head of A.T. Pshonik Department of Physiology of V.F.Voino-Yasenetskii Krasnoyarsk State Medical University</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, руководитель лаборатории молекулярно-клеточной физиологии и патологии НИИ медицинских проблем Севера, заведующий кафедрой физиологии им. проф. А.Т. Пшоника КрасГМУ им. проф. В.Ф. Войно-Ясенецкого</p></bio><email>aasavchenko@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zdzitovetskii</surname><given-names>D. E.</given-names></name><name xml:lang="ru"><surname>Здзитовецкий</surname><given-names>Д. Э.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, assistant professor, Head of Yu.M. Lubenskii Department of Surgery Diseases of V.F.Voino-Yasenetskii Krasnoyarsk State Medical University. Address: 3G, Partizana Zheleznyaka Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 246-94-06</p></bio><email>zdz64@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Borisov</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Борисов</surname><given-names>А. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, leading research scientist of the Laboratory of Molecular cell physiology and pathology of FSBI “Scientific research institute of medical problems of the North”. Address: 3G, Partizana Zheleznyaka Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-06-83</p></bio><email>2885263@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Luzan</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Лузан</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>junior research scientist of the Laboratory of Molecular cell physiology and pathology of FSBI “Scientific research institute of medical problems of the North”. Address: 3G, Partizana Zheleznyaka Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-06-83</p></bio><email>laskimo@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Medical Problems of the North, Krasnoyarsk&#13;
Prof. V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University</institution></aff><aff><institution xml:lang="ru">НИИ медицинских проблем Севера, Красноярск&#13;
Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Russian Federation</institution></aff><aff><institution xml:lang="ru">Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого,&#13;
Российская Федерация</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Institute of Medical Problems of the North, Krasnoyarsk, Russian Federation</institution></aff><aff><institution xml:lang="ru">НИИ медицинских проблем Севера, Красноярск, Российская Федерация</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-10-01" publication-format="electronic"><day>01</day><month>10</month><year>2014</year></pub-date><volume>69</volume><issue>5-6</issue><issue-title xml:lang="en">Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciences</issue-title><issue-title xml:lang="ru">Вестник Российской академии медицинских наук</issue-title><fpage>23</fpage><lpage>28</lpage><history><date date-type="received" iso-8601-date="2015-08-07"><day>07</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1970, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1970, Издательство "Педиатръ"</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/424">https://vestnikramn.spr-journal.ru/jour/article/view/424</self-uri><abstract xml:lang="en"><p><italic><bold>Background</bold>: Aim was to study the chemiluminescent activity and the activity of NAD- and NADP-dependent dehydrogenases of neutrophilsdepending on the outcome of the widespread purulent peritonitis (WPP). <bold>Patients and methods</bold>: 51 patients with a mean age of RSE 54,2±19,2 years were observed. As a control 75 healthy people of similar age range were examined. Lucigenin- and luminol-dependent chemiluminescence activity and activity of NAD(P)-dependent dehydrogenases peripheral blood neutrophils were studied. <bold>Results</bold>: In patients with a favorable outcome of WPP the maximum intensity increased and the magnitude of the activation index of lucigenine-dependent spontaneous chemiluminescence reduced.Regardless to the outcome of WPP in patients with increased activation index and maxima of the luminol-dependent spontaneous and zymosaninduced chemiluminescence. At the unfavorable outcome of the disease in neutrophils NAD- dependent isositrate dehydrogenase and anaerobic lactate dehydrogenase reaction activity increased. Regardless to the outcome WPP in patients neutrophils aerobic reaction of lactate dehydrogenase, glucose-6-phosphate dehydrogenase and NADP-dependent glutamate dehydrogenase activity reduced but levels of NADH-dependent reaction of malate dehydrogenase, NADH-dependent glutamate dehydrogenase and NADP-dependent isocitrate dehydrogenase activity increased. <bold>Conclusion</bold>: With the reduction of the intensity of plastic processes and imbalances enzymatic activity in nitrogen metabolism in patients with WPP at unfavorable outcome of the disease increases the activity of enzymes that characterize the level of anaerobic and aerobic respiration. In the absence of marked changes in the activity of enzymes that characterize the level of energy processes in cells of patients with favorable outcome of the WPP, increases the intensity of spontaneous lucigenin-dependent chemiluminescence and reduced neutrophil activation index.</italic><italic/></p></abstract><trans-abstract xml:lang="ru"><p><italic/></p><p><bold><italic>Цель исследования</italic></bold><italic>: изучить хемилюминесцентную активность и активность НАД- и НАДФ-зависимых дегидрогеназ нейтрофильных</italic> <italic>гранулоцитов в зависимости от исхода распространенного гнойного перитонита (РГП). </italic><bold><italic>Пациенты и методы</italic></bold><italic>: обследован 51 больной РГП</italic> <italic>(средний возраст 54,2±19,2 года). В качестве контроля обследовано 75 здоровых людей аналогичного возрастного диапазона. Изучены</italic> <italic>показатели люцигенин- и люминолзависимой хемилюминесцентной активности и уровни активности НАДФ-зависимых дегидрогеназ</italic> <italic>нейтрофильных гранулоцитов периферической крови. </italic><bold><italic>Результаты</italic></bold><italic>: у больных с благоприятным исходом РГП повышается максимальная</italic> <italic>интенсивность и снижена величина индекса активации люцигенинзависимой спонтанной хемилюминесценции. Независимо от исхода РГП у больных повышаются индекс активации и максимумы интенсивности люминолзависимой спонтанной и зимозаниндуцированной хемилюминесценции. При неблагоприятном исходе заболевания в нейтрофилах повышена активность НАД-зависимой изоцитратдегидрогеназы и анаэробной реакции лактатдегидрогеназы. Вне зависимости от исхода РГП в нейтрофильных гранулоцитах больных снижена активность аэробной реакции лактатдегидрогеназы, глюкозо-6-фосфатдегидрогеназы и НАДФ-зависимой глутаматдегидрогеназы, но повышены уровни активности НАДН-зависимой реакции малатдегидрогеназы, НАДН-зависимой глутаматдегидрогеназы и НАДФ-зависимой изоцитратдегидрогеназы. </italic><bold><italic>Выводы</italic></bold><italic>: на фоне снижения интенсивности пластических процессов и дисбаланса ферментативной активности в азотистом обмене у больных РГП при неблагоприятном исходе заболевания повышается активность ферментов, характеризующих уровень анаэробного и аэробного дыхания. При отсутствии выраженных изменений активности ферментов, характеризующих уровень энергетических процессов в клетках у больных РГП при благоприятном исходе заболевания, повышается интенсивность спонтанной люцигенинзависимой хемилюминесценции и снижается индекс активации нейтрофилов.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>peritonitis</kwd><kwd>neutrophils</kwd><kwd>chemiluminescent activity</kwd><kwd>metabolism</kwd><kwd>dehydrogenases</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>перитонит</kwd><kwd>нейтрофильные гранулоциты</kwd><kwd>хемилюминесцентная активность</kwd><kwd>метаболизм</kwd><kwd>дегидрогеназы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Sukovatykh B.S., Blinkov Yu.Yu., Bukreeva A.E., Eshtokin S.A., Ivanov P.A., Zhukovskii V.A. Vestn. khirurgii im. I.I. Grekova = I.I. Grekov Bulletin of surgery. 2011; 170(6): 32–36.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Wiest R., Krag A., Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012; 61 (2): 297–310.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Yarilin A.A. Immunologiya [Immunology]. Moscow, GEOTAR-Media, 2010. 752 p.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Wright H.L., Moots R.J., Bucknall R.C., Edwards S.W. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford). 2010; 49 (9): 1618–1631.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Kurtasova L.M., Savchenko A.A., Shkapova E.A. Klinicheskie aspekty funktsional'nykh narushenii neitrofil'nykh granulotsitov pri onkopatologii [Neutrocyte Functional Diseases’ Clinical Aspects under Oncopathology]. Novosibirsk, Nauka, 2009. 184 p.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 2013; 13 (3): 159–175.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Vladimirov Yu.A., Proskurina E.V. Usp. biol. khimii = Achievements of biological chemistry. 2009; 49: 341–388.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Benbarek H., Ayad A., Deby-Dupont G., Boukraa L., Serteyn D. Modulatory effects of non-steroidal anti-inflammatory drugs on the luminol and lucigenin amplified chemiluminescence of equine neutrophils. Vet. Res. Commun. 2012; 36 (1): 29–33.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Le Gall J.-R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993; 270: 2957–2963.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Savel'ev V.S., Filimonov M.I., Gel'fand B.R. Annaly khirurgii = Annals of surgery. 1996; 3: 25–29.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Linder M. M., Wacha H., Feldmann U., Wesch G., Streifensand R.A., Gundlach E. Der Mannheimer Peritonitis-Index. Ein Instrument zur intraoperativen Prognose der Peritonitis. Chirurg. 1987; 58: 84–91.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22 (7): 707–710.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Bone R.S., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. American college of Chest Physicians. Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guide lines for the use of innovative therapies in sepsis. Crit. Care Med. 1992; 20 (6): 864–874.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Savchenko A.A., Suntsova L.N. Lab. delo = Laboratory work. 1989; 11: 23–25.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Knorre D.G., Myzina S.D. Biologicheskaya khimiya [Biological Chemistry]. Novosibirsk, Izd-vo SO RAN, 2012. 456 p.</mixed-citation></ref></ref-list></back></article>
